Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
NCT01139957 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1916
Last updated 2020-09-02
Summary
This clinical trial is studying the incidence of cancer in women at increased genetic risk of ovarian cancer. Gathering information about genetic factors in women with an increased risk of ovarian cancer over time may help doctors learn more about the disease and find better methods of treatment and on-going care.
Conditions
- Breast Carcinoma
- Fallopian Tube Carcinoma
- Ovarian Neoplasm
- Primary Peritoneal Carcinoma
Interventions
- PROCEDURE
-
Evaluation of Cancer Risk Factors
Ancillary studies
- OTHER
-
Quality-of-Life Assessment
Ancillary studies
- OTHER
-
Questionnaire Administration
Ancillary studies
- PROCEDURE
-
Study of High Risk Factors
Ancillary studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Gynecologic Oncology Group
lead NETWORK
Principal Investigators
-
Mark H Greene · Gynecologic Oncology Group
Eligibility
- Min Age
- 30 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-06-07
- Primary Completion
- 2020-04-10
- Completion
- 2020-04-10
Countries
- United States
Study Locations
More Related Trials
-
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
NCT05287451 ·Status: RECRUITING ·Phase: NA
-
Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer
NCT03656809 ·Status: COMPLETED
-
Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
NCT00238342 ·Status: UNKNOWN ·Phase: NA
-
Prophylactic Salpingectomy With Delayed Oophorectomy
NCT01907789 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Risk of Ovarian Cancer in Patients With a Pelvic Mass
NCT00315692 ·Status: COMPLETED
-
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
NCT06312124 ·Status: RECRUITING ·Phase: NA
-
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
NCT01074398 ·Status: UNKNOWN
-
Screening Women at High Genetic Risk for Ovarian Cancer
NCT00033488 ·Status: COMPLETED ·Phase: NA
-
Healthy Volunteers Study
NCT06962059 ·Status: RECRUITING
-
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
NCT00003794 ·Status: TERMINATED
-
Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands
NCT07039552 ·Status: RECRUITING
-
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
NCT04794322 ·Status: RECRUITING
-
Prognostic and Predictive Biomarkers in Ovarian Cancers
NCT03010124 ·Status: RECRUITING ·Phase: NA
-
Ovarian Cancer Risk Estimation in Patients With Pelvic Mass
NCT00987649 ·Status: COMPLETED
-
BrUOG 390: Neoadjuvant Treatment With Talazoparib
NCT04598321 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
NCT00757263 ·Status: UNKNOWN
-
Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer
NCT06775470 ·Status: RECRUITING
-
Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System
NCT00837993 ·Status: COMPLETED
-
Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
NCT00445887 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy
NCT06240598 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer
NCT00699907 ·Status: COMPLETED ·Phase: PHASE2
-
Reproductive Health Program in Patients With Cancer
NCT01806129 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants
NCT00628654 ·Status: COMPLETED
-
A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants
NCT04487405 ·Status: TERMINATED
-
Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage
NCT03150121 ·Status: UNKNOWN ·Phase: NA